Nebulized Hypertonic Saline (3%) Versus Nebulized Adrenaline for Treatment of Bronchiolitis
Launched by MAULANA AZAD MEDICAL COLLEGE · Aug 2, 2018
Trial Information
Current as of June 05, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • • Children aged 1 month to 2 years with moderate to severe bronchiolitis as per Wang score
- Exclusion Criteria:
- • Comorbidities such as congenital heart disease, bronchopulmonary dysplasia, cystic fibrosis, neurological diseases
- • Known or suspected immunodeficiency
- • Congenital malformations
- • History of use of steroids within one week prior to presentation
- • Severe disease requiring admission to intensive care unit/mechanical ventilation
About Maulana Azad Medical College
Maulana Azad Medical College (MAMC) is a prestigious institution located in New Delhi, India, renowned for its commitment to advancing medical education, research, and healthcare. As a leading clinical trial sponsor, MAMC leverages its extensive academic resources and expertise to conduct innovative research aimed at improving patient outcomes and understanding disease mechanisms. The college fosters collaborations with various healthcare professionals and institutions, ensuring the highest standards of ethical practices and scientific rigor in its clinical trials. Through its dedication to excellence, MAMC plays a pivotal role in contributing to the global medical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New Delhi, Delhi, India
Patients applied
Trial Officials
Jerin C Sekhar, MD
Principal Investigator
Maulana Azad Medical College
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials